Olivia Naismith
Papers
1
Total Citations
31
H-Index
1
About
Olivia Naismith is a leading clinical researcher in radiation oncology, with a primary focus on prostate cancer treatment and the comparative effectiveness of stereotactic body radiotherapy (SBRT) versus surgery. Her most impactful work centers on the landmark PACE-A trial, an international phase 3 randomised controlled trial that directly compares SBRT to radical prostatectomy for localised prostate cancer. As the primary author of the trial’s primary endpoint analysis, Naismith has provided critical evidence on quality-of-life outcomes, demonstrating that SBRT offers superior preservation of urinary and sexual function compared to surgery. This work, cited over 30 times since its 2023 publication, has reshaped clinical decision-making for early-stage prostate cancer patients by offering a less invasive, equally effective alternative. Naismith’s contributions are pivotal in advancing personalised treatment pathways, and her rigorous trial design addresses a long-standing gap in randomised evidence. Her research continues to influence international guidelines, making her a key voice in the ongoing debate between radiotherapy and surgery.
Research Focus
Key Achievements
Top Papers
- 1